USPSTF Guidelines Flashcards
Created 7.7.18
USPSTF Recommendation and Grade - Abdominal Aortic Aneurysm Screening for Men Ages 65 to 75 who Have Ever Smoked
One-time screening for Abdominal Aortic Aneurysm with ultrasonography in men ages 65-75 years who have EVER smoked
Grade B
*Update in progress
USPSTF Recommendation and Grade - Abdominal Aortic Aneurysm Screening for Men Ages 65 to 75 who Have Never Smoked
Selectively offer screening for AAA in men ages 65-75 years who have NEVER smoked
Grade C
*Update in progress
USPSTF Recommendation and Grade - Abdominal Aortic Aneurysm Screening for Women Ages 65 to 75 who Have Ever Smoked
Current evidence is insufficient to assess the balance of benefits and harms of screening for AAA in women ages 65-75 years who have ever smoked
Grade I
*Update in progress
USPSTF Recommendation and Grade - Abdominal Aortic Aneurysm Screening for Women Ages 65 to 75 who Have Never Smoked
Recommends against routine screening for AAA in women who have never smoked
Grade D
*Update in progress
USPSTF Recommendation and Grade - Abnormal Blood Glucose and Type 2 Diabetes Mellitus Screening
Recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40-70 years who are overweigh or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity.
Grade B
*Update in progress
How does the USPSTF Recommendation for Abnormal Blood Glucose and Type 2 Diabetes Mellitus Screening change based on risk factors?
Persons who have a family history of diabetes, have a history of gestational diabetes or PCOS, or are members of certain racial/ethnic groups (African American, American Indian or Alaskan Natives, Asian Americans, Hispanics or Latinos, or Native Hawaiians or Pacific Islanders) may be at increased risk for diabetes at a younger age or at a lower BMI. Clinicians should consider screening earlier in persons with 1+ of these characteristics.
USPSTF Recommendation and Grade - Adolescent Idiopathic Scoliosis Screening
Current evidence is insufficient to assess the balance of benefits and harms of screening for adolescent idiopathic scoliosis in children and adolescents aged 10-18 years.
Grade I
USPSTF Recommendation and Grade - Alcohol Misuse - Screening and Behavioral Counseling Interventions in Primary Care for Adults aged 18 and older
Screen adults aged 18 years or older for alcohol misuse and provide persons engaged in risky or hazardous drinking with brief behavioral counseling interventions to reduce alcohol misuse
Grade B
*Update in progress
Note - the 2018 draft recommendation statement is updated to include pregnant women
USPSTF Recommendation and Grade - Alcohol Misuse - Screening and Behavioral Counseling Interventions in Primary Care for Adolescents (under 18 years of age)
Current evidence is insufficient to assess the balance of benefits and harms of screening and behavioral counseling interventions in primary care setting s to reduce interventions to reduce alcohol misuse in adolescents
Grade I
*Update in progress
USPSTF Recommendation and Grade - Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer - Adults aged 50 to 59 years with a 10% or higher 10-year CVD risk
Recommends initiating low-dose aspirin use for the primary prevention of CVD and CRC in adults aged 50-59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years
Grade B
USPSTF Recommendation and Grade - Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer - Adults aged 60 to 69 years with a 10% or higher 10-year CVD risk
The decision to initiate low-dose aspirin use for the primary prevention of CVD and CRC in adults aged 60-69 years who have a 10% or greater 10-year CVD risk should be an individual one. Persons who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years are more likely to benefit. Persons who place a higher value on the potential benefits than the potential harms may choose to initiate low-dose aspirin.
Grade C
USPSTF Recommendation and Grade - Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer - Adults younger than 50 years or 70+ years
Current evidence is insufficient to assess the balance of benefits and harms of initiating aspirin use for the primary prevention of CVD and CRC
Grade I
USPSTF Recommendation and Grade - Asymptomatic Bacteriuria in Adults - Screening
Screen for asymptomatic bacteriuria with urine culture for pregnant women at 12-16 weeks’ gestation or at their first prenatal visit, if later
Grade A
Recommends against screening for asymptomatic bacteriuria in men and non-pregnant women
Grade D
*Update in progress
Autism Spectrum Disorder in Young Children - Screening
Current evidence is insufficient to assess the balance of benefits and harms of screening for ASD in young children (18-30 months) for whom no concerns of ASD have been raised by their parents or a clinician
Grade I
USPSTF Recommendation and Grade - Bacterial Vaginosis in Pregnancy to Prevent Preterm Delivery
Recommends against screening for bacterial vaginosis in asymptomatic pregnant women at low risk for preterm delivery
Grade D
Current evidence is insufficient to assess the balance of benefits and harms of screening for bacterial vaginosis in asymptomatic pregnant women at high risk for preterm delivery
Grade I
Update in progress
USPSTF Recommendation and Grade - Bladder Cancer Screening in Adults
Current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults
Grade I
USPSTF Recommendation and Grade - Blood Pressure Screening in Children and Adolescents (Hypertension)
Current evidence is insufficient to assess the balance of benefits and harms of screening for primary hypertension in asymptomatic children and adolescents to prevent subsequent cardiovascular disease in childhood or adulthood
Grade I
*Update in progress
USPSTF Recommendation and Grade - BRCA-Related Cancer - Risk Assessment, Genetic Counseling, and Genetic Testing
Screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with 1 of several screening tools designed to identify a family history that may be associated with an increased risk for potentially harmful mutations in breast cancer susceptibility genes (BRCA1 or BRCA2). Women with positive screening results should receive genetic counseling and, if indicated after counseling, BRCA testing
Grade B
Recommends against routine genetic counseling or BRCA testing for women whose family history is not associated with an increased risk for potentially harmful mutations in the BRCA1 or BRCA2 genes.
Grade D
*Update in progress
USPSTF Recommendation and Grade - Breast Cancer - Medications for Risk Reduction
Clinicians engage in shared, informed decision making with women who are at increased risk for breast cancer about medications to reduce their risk. For women who are at increased risk for breast cancer and at low risk for adverse medication effects, clinicians should offer to prescribe risk-reducing medications, such as tamoxifen or raloxifene
Grade B
Recommends against the routine use of medications, such as tamoxifen or raloxifene, for risk reduction of primary breast cancer in women who are not at increased risk for breast cancer.
Grade D
*Update in progress
USPSTF Recommendation and Grade - Breast Cancer Screening
Biennial screening mammography for women aged 50-74 years
Grade B
Decision to start screening mammography in women prior to age 50 years should be an individual one. Women who place a higher value on the potential benefit than the potential harms may choose to begin biennial screening between 40-49 years.
Grade C
Current evidence is insufficient to assess the balance of benefits and harms of screening mammography in women aged 75 years or older
Grade I
(See USPSTF website for more details)
USPSTF Recommendation and Grade - Breast Cancer Screening with digital breast tomosynthesis (DBT) for all women
Current evidence is insufficient to assess the balance of benefits and harms of DBT as a primary screening method for breast cancer
Grade I
USPSTF Recommendation and Grade - Breast Cancer Screening for women with dense breasts
Current evidence is insufficient to assess the balance of benefits and harms of adjunctive screening for breast cancer using breast ultrasonography, magnetic resonance imaging, DBT, or other methods in women identified to have dense breasts on an otherwise negative screening mammogram
Grade I
The breast cancer screening USPSTF recommendations apply to which populations?
Asymptomatic women aged 40 years or older who do not have pre-existing breast cancer of a previously diagnosed high-risk breast lesion and who are not at high risk for breast cancer because of a known underlying genetic mutation (such as BRCA1 or BRCA2 gene mutation or other familial breast cancer syndrome) or a history of chest radiation at a young age
USPSTF Recommendation and Grade - Breastfeeding
Recommends providing interventions during pregnancy and after birth to support breastfeeding
Grade B
USPSTF Recommendation and Grade - Cardiovascular Disease Risk - Screening with Electrocardiography
Recommends against screening with resting or exercise EECG to prevent CVD events in asymptomatic adults at low risk of CVD events
Grade D
Current evidence is insufficient to assess the balance of benefits and harms of screening with resting or exercise ECG to prevent CVD events in asymptomatic adults at intermediate or high risk of CVD events.
Grade I
USPSTF Recommendation and Grade - Carotid Artery Stenosis - Screening
Recommends against screening for asymptomatic carotid artery stenosis in the general adult population
Grade D
USPSTF Recommendation and Grade - Celiac Disease Screening
Current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons
Grade I
USPSTF Recommendation and Grade - Cervical Cancer Screening
Screening for cervical cancer in women age 21-65 years with cytology (Pap smear) alone every 3 years or, for women age 30-65 years who want to lengthen the screening interval, screening with a combination of cytology and HPV testing every 5 years
Grade A
*Update in progress
Update recommends screening for cervical cancer every 3 years with cervical cytology alone in women ages 21 to 29 years; recommends either screening every 3 years with cervical cytology alone or every 5 years with high-risk HPV testing alone in women ages 30-65 years
USPSTF Recommendation and Grade - Cervical Cancer Screening - who should not be screened?
Women younger than 21 years
Women older than 65 who have had adequate prior screening and are not otherwise at high risk for cervical cancer
Women who have had a hysterectomy with removal of the cervix and who do not have a history of a high-grade precancerous lesion or cervical cancer
Grade D (all)
*Update in progress
To whom does the Cervical Cancer Screening recommendations apply?
Women who have a cervix, regardless of sexual history
It does NOT apply to women who have received a diagnosis of a high-grade precancerous lesion or cervical cancer, women with DES exposure in utero, or women who are immunocompromised.
USPSTF Recommendation and Grade - Child Maltreatment - Primary Care Interventions
Current evidence is insufficient to assess the balance of benefits and harms of primary care interventions to prevent child maltreatment. This recommendation applies to children who do not have signs or symptoms of maltreatment
Grade I
- Update in progress
- Update clarifies the population as children and adolescents age 18 years and younger
USPSTF Recommendation and Grade - Chlamydia and Gonorrhea Screening
Screen for chlamydia and gonorrhea in sexually active women age 24 years and younger and in older women who are at increased risk for infection
Grade B
Current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men
Grade I
USPSTF Recommendation and Grade - Chronic Obstructive Pulmonary Disease Screening
Recommends against screening for COPD in asymptomatic adults
Grade D
USPSTF Recommendation and Grade - Cognitive Impairment in Older Adults - Screening
Current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment
Grade I
*Update in progress
USPSTF Recommendation and Grade - Colorectal Cancer Screening
Screen for colorectal cancer starting at age 50 years and continuing until age 75 years
Grade A
The decision to screen for colorectal cancer in adults aged 76-85 years should be an individual one, taking into account the patient’s overall health and prior screening history. Adults in this age group who have never been screened are more likely to benefit. Screening would be most appropriate among adults who 1) are healthy enough to undergo treatment if colorectal cancer is detected and 2) do not have comorbid conditions that would significantly limit their life expectancy
Grade C
USPSTF Recommendation and Grade - Congenital Hypothyroidism Screening
Topic referred to the Advisory Committee on Heritable Disorders in Newborns and Children - it recommends that every newborn screening program include a Uniform Screening Panel that screens for 34 core disorders and 26 secondary disorderes
USPSTF Recommendation and Grade - Coronary Heart Disease - Screening Using Non-Traditional Risk Factors
Current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors studied to screen asymptomatic men and women with no history of CHD to prevent CHD events
Grade I
- Update in progress
- Update changes the population to “asymptomatic adults”
What are the non-traditional risk factors for coronary heart disease?
High-sensitivity C-reactive protein (hs-CRP), ankle-brachial index (ABI), leukocyte count, fasting blood glucose level, periodontal disease, carotid intima-media thickness (carotid IMT), coronary artery calcification (CAC) score on electron-beam computed tomography (EBCT), homocysteine level, and lipoprotein(a) level
*Update excludes leukocyte count, fasting blood glucose level, periodontal disease, carotid IMT, homocysteine level, and lipoprotein(a) level from this list